Vikas Sinha joined MPM in 2018 as a Managing Director. He brings to this role more than 20 years of experience working in executive finance roles in the life sciences industry and will contribute to the firm’s company-building approach for key portfolio investments.

Prior to joining MPM, Vikas served as the CFO of Alexion Pharmaceuticals for 11 years and was responsible for finance, business development, strategy and IT. During his tenure as CFO, Alexion’s market cap grew from $600 million to more than $30 billion and revenue grew from zero to more than $3 billion. He was recognized five times by Institutional Investors with its “Best CFO Award for Biotechnology.”

Prior to joining Alexion, Vikas held various positions with Bayer AG in the United States, Japan, Germany and Canada, including Vice President and CFO of Bayer Pharmaceuticals Corporation, USA, Vice President and Chief Financial Officer of Bayer Yakuhin Ltd., in Japan.

Vikas received his M.B.A. from the Asian Institute of Management. He is also a qualified Chartered Accountant from the Institute of Chartered Accountants of India and a Certified Public Accountant in the United States. Vikas is currently an independent board member and Audit Committee chair of Verona Pharma Inc.